药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Ipidacrine
Ipidacrine may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Tyrothricin
Tyrothricin may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Paraoxon
Paraoxon may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Methanesulfonyl Fluoride
Methanesulfonyl Fluoride may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Acotiamide
Acotiamide may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Metrifonate
Metrifonate may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Fenthion
Fenthion may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Dichlorvos
Dichlorvos may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Coumaphos
Coumaphos may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Glycine betaine
Glycine betaine may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Aprotinin
Aprotinin may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Regramostim
Regramostim may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Phenserine
Phenserine may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Huperzine A
Huperzine A may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Thiotepa
Thiotepa may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
1,10-Phenanthroline
1,10-Phenanthroline may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Bambuterol
Bambuterol may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Ginkgo biloba
Ginkgo biloba may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Naxitamab
The risk or severity of hypertension can be increased when Mirabegron is combined with Naxitamab.
Pirbuterol
Selpercatinib
The risk or severity of hypertension can be increased when Mirabegron is combined with Selpercatinib.